Blueshift Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,769
Closed -$232K 535
2025
Q1
$232K Buy
+2,769
New +$258K 0.09% 321

Other funds holding LMAT

Blueshift Asset Management's LMAT Position: Q2 2025 in Review

Blueshift Asset Management sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 2,769 shares — an estimated $232K sold.

Blueshift Asset Management first reported a position in LMAT in Q1 2025 and held it in 1 quarter. The position peaked at $232K in Q1 2025. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

  • Blueshift Asset Management reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
  • Blueshift Asset Management sold 2,769 LeMaitre Vascular shares in Q2 2025, an estimated $232K.
  • Blueshift Asset Management first reported a position in LeMaitre Vascular in Q1 2025 and held it in 1 quarter.
  • Blueshift Asset Management's LeMaitre Vascular position peaked at $232K in Q1 2025.
  • 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Blueshift Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.